Ying Luo

机构：Nankai University, Tianjin Third Central Hospital, Shanghai Institute of Pharmaceutical Industry, Tianjin Medical University · ORCID：0000-0003-0252-0053

发表论文 8 篇 · 总被引 94 次 · h-index 5

代表论文

• Solubility measurement, model evaluation and molecular simulations of aprepitant (form I) in eight pure solvents (2020 · Journal of Molecular Liquids · 被引 49)
• Metabolic perturbation of epigenome by inhibiting S -adenosylhomocysteine hydrolase elicits senescence through DNA damage response in hepatoma cells (2017 · Tumor Biology · 被引 13)
• Sequential release of vascular endothelial growth factor and platelet-derived growth factor at the appropriate time for improved angiogenesis (2025 · Acta Biomaterialia · 被引 11)
• Additive-free preparation of hemodialysis membranes from silibinin-modified polysulfone polymer with enhanced performance in anti-oxidative stress and hemocompatibility (2024 · Journal of Membrane Science · 被引 10)
• Comparison of resmetirom quantative analysis in API and formulation models based on PXRD, FTIR and Raman scanning imaging combined with univariate and multivariate analyses (2025 · Talanta · 被引 5)
• Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles in Liver Injury (2024 · Biomedicines · 被引 3)